Disulfiram: Dopamine β-Hydroxylase Inhibitor for Cancer Rese
2026-08-04
Disulfiram, best known as an anti-alcoholism drug, has emerged as a powerful dopamine β-hydroxylase inhibitor and proteasome modulator in cancer research. Explore stepwise protocols, troubleshooting strategies, and insights from landmark studies to maximize its impact in synthetic lethality and apoptotic cancer cell death induction.
nor-NOHA Acetate: Strategic Arginase Inhibition in Translati
2026-08-03
This in-depth thought-leadership article explores the mechanistic and strategic dimensions of nor-NOHA (acetate) as a potent arginase inhibitor in cancer immunometabolism. By synthesizing recent advances—including immune escape mechanisms and translational workflow optimization—it offers actionable guidance for researchers aiming to bridge basic metabolic insights with high-impact experimental design. The discussion uniquely integrates evidence from foundational studies and highlights APExBIO’s nor-NOHA (acetate) as a pivotal tool for dissecting arginine metabolism in tumor and immune contexts.
Fangchinoline Restores TFEB-Driven Lysosomal Biogenesis in H
2026-08-03
The reference study identifies fangchinoline as a potent modulator of lysosomal biogenesis via TFEB activation, restoring host cell antiviral defense mechanisms disrupted by H1N1 influenza. This work advances the mechanistic understanding of host-directed antiviral strategies focused on lysosomal function and highlights experimental approaches for targeting intracellular viral evasion.
Structural Basis of HCAR3 Agonist Selectivity Revealed by Cr
2026-08-02
This study presents high-resolution cryo-EM structures of the hydroxycarboxylic acid receptor HCAR3 in complex with selective agonists, including Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid). These structural insights clarify ligand recognition mechanisms, enabling the rational design of hypolipidemic agents and advancing lipid metabolism research.
Cy5.5 NHS Ester (Non-Sulfonated): Precision NIR Labeling for
2026-08-01
Cy5.5 NHS ester (non-sulfonated) enables covalent, high-sensitivity labeling of amino-containing biomolecules for near-infrared fluorescence imaging. Its excitation at 684 nm and emission near 710 nm make it ideal for deep-tissue and in vivo applications. Robust chemical stability and a high extinction coefficient support its use in demanding molecular and cellular workflows.
Nuclear cGAS-TRIM41 Axis Suppresses L1 Retrotransposition vi
2026-07-31
This study uncovers a phosphorylation-dependent mechanism by which nuclear cGAS restricts LINE-1 (L1) retrotransposition, enhancing genome stability. By facilitating TRIM41-mediated degradation of ORF2p through Chk2-mediated phosphorylation, the work reveals new layers in the DNA damage response and its relevance to aging and cancer.
10 mM dNTP Mixture: Optimizing DNA Synthesis Workflows
2026-07-31
Unlock high-fidelity DNA synthesis and robust PCR with the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. Explore advanced workflow enhancements, troubleshooting strategies, and translational insights grounded in recent nanoparticle delivery research.
Prostaglandin E2: Immune Modulation, Protocols, and Translat
2026-07-30
Explore the multifaceted role of Prostaglandin E2 (PGE2) in immune regulation, assay design, and translational research. This article uniquely bridges lipid-derived autacoids with practical protocols, referencing emerging humoral immunity insights.
Ro 3306: Precision CDK1 Inhibition for G2/M Cell Cycle Arres
2026-07-30
Ro 3306 stands at the forefront of selective CDK1 inhibition, empowering researchers to achieve robust, reproducible G2/M phase arrest and dissect DNA repair mechanisms with precision. This guide integrates the latest findings on mTORC1 oscillations, optimized workflows, and troubleshooting strategies to maximize the impact of Ro 3306 in cancer research and cell cycle studies.
KU-55933: Advancing ATM Kinase Inhibitor Use in Metabolic &
2026-07-29
Explore how KU-55933, a potent ATM kinase inhibitor, unlocks new frontiers in DNA damage response and metabolic research. This article uniquely bridges molecular mechanisms with emerging cardiac applications, offering fresh insights for assay development.
Chloroquine Diphosphate: Unraveling Autophagy–Immunity Cross
2026-07-29
Explore the advanced role of Chloroquine diphosphate in dissecting autophagy–innate immunity interplay for cancer research. This article provides unique insights into its mechanistic utility and experimental design, building on the latest findings.
Mechanistic Insights into Diuron-Induced Acute Renal Injury
2026-07-28
This study integrates network toxicology and experimental validation to elucidate how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury (AKI) via the JAK2/STAT1 pathway. The findings advance mechanistic understanding for both environmental toxicology and risk assessment, providing a basis for future research into pesticide nephrotoxicity.
PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration
2026-07-28
This study uncovers how unresolved endoplasmic reticulum stress (ERS) in nucleus pulposus cells leads to pyroptosis and inflammation via PERK-dependent JAK1–STAT3 signaling, advancing our understanding of intervertebral disc degeneration (IDD) mechanisms. These findings offer a mechanistic basis for targeting the PERK/eIF2α/ATF4–JAK1–STAT3 pathway to mitigate disc cell loss and inflammation in degenerative conditions.
T0070907: Precision PPARγ Antagonist for Pathway Dissection
2026-07-27
T0070907 empowers researchers to dissect the PPARγ signaling pathway with nanomolar specificity, enabling advanced studies in adipogenesis inhibition, cell cycle arrest, and inflammatory pathway modulation. Its robust performance and validated protocols provide a reliable foundation for both standard and innovative experimental workflows.
Ibuprofen Toxicology and Environmental Biodegradation Insigh
2026-07-27
Janet Jan-Roblero and Juan A. Cruz-Maya’s review details the emerging threat of ibuprofen as an environmental contaminant, highlighting its toxicological effects and the challenges of biodegradation. The article underscores the need for more robust research and remediation protocols, particularly due to the widespread use and environmental persistence of nonsteroidal anti-inflammatory drugs.
479 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page